About LENSAR, Inc. 
LENSAR, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 14 Schemes (15.46%)
Foreign Institutions
Held by 25 Foreign Institutions (5.91%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
16 Million
(Quarterly Results - Dec 2025)
Net Profit:
-1 Million
Pharmaceuticals & Biotechnology
USD 123 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
1.33
167.57%
-10.11






